Clinical trial
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate…
NCT00493363 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00493363 |
|---|---|
| Title | Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia |
| Official title | Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia |
| Lead sponsor | University of Oxford, Other |
| Collaborators | World Health Organization NCHADS - Ministry of Health of Cambodia Mahidol University Institut Pasteur Industry FHI 360 Li Ka Shing Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Artesunate, Artesunate + Mefloquine |
| Enrollment | 40 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 28, 2007 |
| Last update posted | May 4, 2018 |
| Countries | Cambodia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: